Frontlight ResearchEarly access
Trial site
Institut de Cancérologie de Lorraine Alexis Vautrin
- 4running trials
- 4closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer3 trials
- Head and neck cancer2 trials
- Brain metastases1 trial
- Kidney cancer1 trial
- Ovarian cancer1 trial
- Phase
- Phase 23 trials
- Phase 33 trials
- Phase 1/21 trial
- Status
- Completed4 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Lead sponsor
- Eli Lilly and Company2 trials
- Centre Leon Berard1 trial
- Daiichi Sankyo1 trial
- Ipsen1 trial
- Pfizer1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer2 recruiting
Closed trials
Completed
Completed
Completed
FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026